Christoph Tasto

Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial

G. Filippatos, L. Ruilope, G. Bakris, 2021, Circulation.

Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin.

Deepak L. Bhatt, S. Yusuf, J. Bosch, 2019, Journal of the American College of Cardiology.

Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes.

G. Filippatos, L. Ruilope, G. Bakris, 2021, Journal of the American College of Cardiology.

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.

Deepak L. Bhatt, S. Yusuf, J. Bosch, 2022, European heart journal. Cardiovascular pharmacotherapy.